Evotec Had Strong H1, Foresees Dual Track Growth After Entering Biologics Space
Executive Summary
Evotec upped its full-year guidance after a strong second quarter that saw an important strategic expansion into the biologics space through the acquisition of Just Biotherapeutics Inc.